{"schema_version":"secwatch.filing_event.v1","accession":"0001437749-23-007022","form_type":"8-K","ticker":"INBP","cik":"0001016504","company_name":"INTEGRATED BIOPHARMA INC","filed_at":"2023-03-17T23:59:59+00:00","discovered_at":"2026-05-14T18:03:43.510486+00:00","generated_at":"2026-06-17T23:25:33.147014+00:00","sec_items":[],"event_type":"debt","sentiment":"neutral","materiality_score":0.15,"calibrated_materiality_score":0.15,"confidence":"high","headline":"Integrated BioPharma amends credit agreement to replace LIBOR with Term SOFR plus 0.10%","bullets":["Fourth Amendment to Revolving Credit, Term Loan and Security Agreement dated March 16, 2023.","Interest rate benchmark changed from LIBOR to Term SOFR Rate plus a 10 basis point SOFR Adjustment.","Outstanding LIBOR-based loans may remain until their term; new requests use Term SOFR.","As of March 16, 2023, no outstanding borrowings or pending requests under the agreement.","Amendment involves Integrated BioPharma and its subsidiaries with PNC Bank as agent."],"urls":{"canonical":"https://secwatch.observer/filing/0001437749-23-007022","json":"https://secwatch.observer/filing/0001437749-23-007022.json","markdown":"https://secwatch.observer/filing/0001437749-23-007022.md","text":"https://secwatch.observer/filing/0001437749-23-007022.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1016504/000143774923007022/0001437749-23-007022-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1016504/000143774923007022/inbp20230316_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-17T23:25:33.147014+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}